AIDS-Associated Kaposi Sarcoma
AIDS-associated KS prognostic index predicts mortality at initial diagnosis
Published in Drug Week, June 30th, 2006
"AIDS-associated Kaposi's sarcoma remains common in individuals with HIV-1 infection in the era of highly active antiretroviral therapy (HAART). We developed a simple model for predicting mortality on the basis of clinical characteristics present at the time of diagnosis of Kaposi's sarcoma," scientists in England report.
According to J. Stebbing and colleagues at Chelsea & Westminster Hospital in London, "Of 5873 individuals with HIV-1 infection, 326 (6%) developed Kaposi's sarcoma; for 262 (80%) this was their first AIDS-defining illness.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-06-30)
More Articles from Drug Week
- Bacterial Meningitis Vaccine
Genome-based vaccine discovery evaluated against meningococcal B strains - Developmental Stuttering
Indevus reports promising phase II data for pagoclone in stuttering - Drug Development
Imagenetix announces positive safety studies on anti-inflammatory compound, 1-TDC - Drug Development
Panacos details study results of maturation inhibitor candidate for HIV - Drug Development
Regeneron receives fast-track designation for the IL-1 Trap in CIAS1-associated periodic syndromes - Acute Lymphoblastic Leukemia
Bioenvision receives European approval for Evoltra - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
